Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. - Current Ratioverified

603707.SS

Price:

$7.4

Market Cap:

$11.96B

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. It also provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium besylate, cisatracurium, calcium folinate, doxorubicin, milrinone, bleomycin, carboplatin, cytarabine, topotecan hydrochloride, phenylephrine hydrochloride, ganirelix acetate, furosemide, glycopyrrolate, neostigmine methylsulfate, succinylcholine chloride, reganosin, isoflurane blue, clofarabine, haloperidol decanoate, busulfan, gemcitabine hydrochloride, dexmedetomidine hydrochloride, nelarabine, rocuronium bromide, zoledronic acid, bupivacaine hy...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-07-19

Stock Exchange

SHH

Ticker

603707.SS

The Current Ratio as of September 2026 (TTM) for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) is 2.15

According to Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.15. This represents a change of -6.13% compared to the average of 2.29 of the last 4 quarters.

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) Historical Current Ratio (quarterly & annually)

How has 603707.SS Current Ratio performed in the past?

The mean historical Current Ratio of Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. over the last ten years is 3.15. The current 2.15 Current Ratio has changed 6.72% with respect to the historical average. Over the past ten years (40 quarters), 603707.SS's Current Ratio was at its highest in in the March 2017 quarter at 6.83. The Current Ratio was at its lowest in in the September 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

3.15

Median

3.03

Minimum

2.11

Maximum

6.10

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 45.05%

Maximum Annual Current Ratio = 6.10

Minimum Annual Increase = -40.80%

Minimum Annual Current Ratio = 2.11

Quarterly (TTM)
Annual
YearCurrent RatioChange
20252.35-31.25%
20243.4145.05%
20232.35-23.27%
20223.070.30%
20213.0626.77%
20202.4114.35%
20192.11-29.59%
20183.00-17.09%
20173.61-40.80%
20166.1015.72%

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) Average Current Ratio

How has 603707.SS Current Ratio performed in the past?

The current Current Ratio of Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.70

5-year avg

2.85

10-year avg

3.15

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) Current Ratio vs. Peers

How is 603707.SS’s Current Ratio compared to its peers?

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.’s Current Ratio is less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (2.31), less than Zhejiang Jingxin Pharmaceutical Co., Ltd. (2.48), less than Pacific Shuanglin Bio-pharmacy Co., Ltd. (3.04), greater than Apeloa Pharmaceutical Co.,Ltd (1.58), less than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (3.91), greater than Shanghai Haoyuan Chemexpress Co., Ltd. (2.08), less than Changzhou Qianhong Biopharma CO.,LTD (6.68), less than Tibet Rhodiola Pharmaceutical Holding Co. Class A (2.87), less than Micro-Tech (Nanjing) Co., Ltd. (3.57), greater than Zhejiang Hisun Pharmaceutical Co., Ltd. (0.93),

Build a custom stock screener for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.'s Current Ratio?

How is the Current Ratio calculated for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS)?

What is the highest Current Ratio for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS)?

What is the 3-year average Current Ratio for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS)?

What is the 5-year average Current Ratio for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS)?

How does the current Current Ratio for Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) compare to its historical average?